@article {SainiS6作者= {Vasu赛和路易斯Guada Dileep r . Yavagal}, title ={全球流行病学的中风和获得急性缺血性中风的干预措施},体积={97}={20补充2},页面= {S6 - S16} = {2021}, doi = {10.1212 / WNL。出版商0000000000012781}= {Wolters Kluwer健康,公司代表美国神经病学学会},文摘={目的评论提供一个最新的评论的中风的发生率和大血管闭塞(LVO)在全球范围内,以首页及资格和静脉溶栓(溶)和机械血栓切除术(MT)。最近发现随机临床试验建立了太有或没有溶LVO中风患者的常规治疗长达24小时从症状出现。资格对诊断和超越基于容许成像标准4.5小时。这些进步在过去的5年,已经有资格的人口显著增加患者急性中风干预措施。然而,获得急性中风保健利用MT或溶滞后在这些患者。总结中风残疾和死亡的第二大原因是全球疾病负担最重的共享的低收入和中等收入国家。2016年,全球有1370万新的事件中风;≈87 \ %的缺血性中风和保守估计大约10 \ % {\ textendash}这些LVO占20 \ %。少于5 \ %的急性缺血性中风患者接受溶在全球合格的治疗时间窗和不到100000 MTs 2016年在全球范围内进行。这凸显了巨大的差距在符合条件的患者和全球低利用率的这些进步。 Multiple global initiatives are underway to investigate interventions to improve systems of care and bridge this gap.AHA/ASA=American Heart Association/American Stroke Association; AIS=acute ischemic stroke; ASPECTS=Alberta Stroke Program Early CT Score; CI=confidence interval; DALY=disability-adjusted life-year; ED=emergency department; HS=hemorrhagic stroke; IS=ischemic stroke; IVT=IV thrombolysis; LVO=large vessel occlusion; MCA=middle cerebral artery; mRS=modified Rankin Scale; MSU=mobile stroke unit; MT=mechanical thrombectomy; MT2020+=Mission Thrombectomy 2020+; mTICI=modified Thrombolysis in Cerebral Infarction; NINDS=National Institute of Neurological Disorders and Stroke; OR=odds ratio; QALY=quality-adjusted life-year; RCT=randomized clinical trial; rtPA=recombinant tissue plasminogen activator}, issn = {0028-3878}, URL = {//www.ez-admanager.com/content/97/20_Supplement_2/S6}, eprint = {//www.ez-admanager.com/content/97/20_Supplement_2/S6.full.pdf}, journal = {Neurology} }